Post-Market Surveillance Gap: Because AOD-9604 never received FDA approval for any indication, there is no post-market surveillance system capturing safety signals from widespread clinical use
Symptoms may include: Extreme fatigue Brain fog Weakness Heart flutters or irregular heartbeat Joint and stomach pain Irritability Depression Iron toxicity is more common in men, postmenopausal women, people with genes for hemochromatosis Types I, II, III, IV, and people living at elevations above 5,000 feet
Certain foods and beverages can deplete glutathione levels
The peptide is most commonly administered once daily in the morning on an empty stomach, though some protocols use twice-daily dosing
Women and men with absorption disorders also cant properly absorb and process it
At 8mg or 12mg weekly, the injection volume exceeds what a standard 1mL insulin syringe can hold